I N D E X , C U R R E N T S C I E N C E R E V I E W S (Revised July 1997) NOTICE: This Index to past Current Science Reviews is revised with each new monthly posting of the CSR. As the revisions are cumulative, you may safely discard any earlier Index. The CSRs are posted for the benefit of those listmembers interested in the status of PD research. For a slightly more detailed explanation of what this is all about, please see the Introduction dated June 97. SUBJECT CSR SOURCE JOURNAL JOURNAL REF. DATE Absorption, levodopa Jun 96 Neur 1996;46:1051-1054 Acetazolamide (Diamox) Nov 95 Movement Disorders 1993;8:240-241 " Jun 96 Neur 1995;458-460 Acetyl-L Carnitine Oct 96 Neur 1996;47:705-711 ADHD, and dopamine Sep 96 Lancet 27 Jul 1996:255 Agonists, action May 95 Neur 1995;45S3:S5 Albuterol Dec 94 Neur 1994;8:1511-1513 Alternative medicine Oct 96 BMJ 17 Aug 1996 Alzheimer's and PD Apr 95 Ann Neur 1995;37:300-312 " " " Nov 96 J Neur N'surg Psych 1996;61:391-387 Amantadine (Symmetrel) Jul 96 Neur 1996;46:1551-1556 Anticipation Feb 97 Neur 1996;47:1512-1517 Antioxidants, dietary May 97 Movem't Dis 1997;12:190-195 Apolipoprotein E Nov 96 J Neur N'surg Psych 1996;61:347-351 Apomorphine, PD effcts Dec 94 J Neur N'surg Psych 1994;8:998-1001 " , " Aug 96 J Neur N'surg Psych 1996;61:634-637 " , " May 97 Clin Neuropharm 1997;20:165-167 " , availability Apr 95 Lancet 1995;345:517-518 ", self-injection Jul 95 J Neur N'surg Psych 1995;58:681-687 ", and libido May 97 Clin Neuropharm 1997;20:140-147 Apoptosis Feb 96 Ann Neur 1995;38:839-851 " Dec 96 Science News 16 Nov 96:316 " Mar 97 Science 21 Feb 97;1081-82 " Apr 97 J Neurosci 1997;17:1075-1085 " Apr 97 J Neurosci 1007;17:1397-1405 " ,l-dopa induced Feb 97 Movem't Dis 1997;12:17-23 Artane, withdrawal Mar 97 Ann Neur 1997;41:133 Autonomous deficit Apr 97 Neur 1997;48:662-667 Axial motor control Feb 97 J Neur N'surg Psych 1996;61:645-648 Blink reflex, and PD Dec 96 J Neurosci 1996;16:7308-7330 Botulinum toxin Jun 96 Neur 1995;45:822-824 " Aug 96 Arch Neur 1996;53:617-624 " Aug 96 J Neur N'surg Psych 1996;61:693 Boxers, parkinsonism Jul 95 J Neur N'surg Psych 1995;58:688-691 Brain injury Jan 97 Neur 1996;47:1358-1359 Bradykinesia Sep 96 Brain 1996;119:801-813 Bromocryptine Dec 94 J Neur N'surg Psych 1994;8:903-910 " Mar 96 Lancet 20 Jan 1996:196 " plus levodopa May 97 Clin Neuropharm 1997;20;67-76 Bruxism Feb 97 Movem't Dis 1997;12:73-78 Cabergoline Jan 95 Arch Neur 1994;51:1236-1241 " Dec 95 Lancet 11 Nov 1995:1290 " Jun 96 Neur 1996;46:1062-1065 " Mar 97 Neur 1997;48:363-368 Carnitine, Acetyl-L Oct 96 Neur 1996:47:705-711 Cerebellum, in ET Jun 96 Neur 1996;46:1200-1205 " " Jun 96 Ann Neur 1996;39:650-658 " ,cognition in May 97 Science 28 Mar 97:1940-43 Chocolate and red wine Oct 96 Lancet 21 Sep 96:834 Cinnarizine Feb 97 Movem't Dis 1997;12:107-110 Clozapine (Clozaril) Apr 95 Lancet 1995;345:517-518 " Apr 95 Neur 1995;45:432-434 " Jan 97 BMJ 16 Nov 1996:1313 " for dyskinesia Apr 97 Neur 1997;48:658-662 " relieves "off" May 97 Movem't Dis 1997;12:159-166 " for tremor May 97 Neur 1997;48:1077-1091 Cocaine, effect Jan 97 J Neurosci 1996;16:7670-7677 Cognitive decline Feb 95 J Neur N'surg Psych 1995;58:51-55 " Jun 96 J Neur N'surg Psych 1996;60:564-571 " Jan 97 J Neurosci 1996;16:7768-7775 " Mar 97 Brain 1996;119:2121-32 " Mar 97 Neur 1997;48:546-547 " Apr 97 Arch Neur 1997;54:296-302 Color discrimination Mar 95 Neur 1995;45:386-387 " Jul 95 Brain 1995;118:771-778 Complex I (enzyme) Nov 96 Ann Neur 1996;40:663-671 " Feb 97 Movem't Dis 1997;12:3-8 Constipation Nov 95 Lancet 1995;346:861-864 DATATOP Nov 95 Arch Neur 1995;52:565-570 " Mar 96 Ann Neur 1996;39:29-36 " Mar 97 Ann Neur 1996;40:946-949 " , end point in May 97 Movem't Dis 1997;12:183-189 Deep-brain stimulation Oct 96 Arch Neur 1996;53:898-903 " Jun 96 Neur 1996;46:1150-1153 " vs pallidotomy Jul 97 Nature Med 1997;3:671-674 " " Jul 97 Nature Med 1997;3:602-603 Dementia, PD vs AD Jul 95 Neur 1995;45:1025 " , Downs and Apr 97 J Neur N'Surg Psych 1997;62:289 " ,frontotemporal Jul 97 Ann Neur 1997;41:706-715 " , preclinical Jan 96 Neur 1995;45:1691-1696 " , incidence Jun 96 Neur 1995;45:705-708 " , " Jul 96 Arch Neur 1996;53:538-542 " , tacrine for Oct 96 J Neur N'surg Psych 1996;61:324-325 " , wine prevents May 97 BMJ 5 Apr 97:997 Depression Mar 96 Arch Neur 1996;53:175-179 " Jan 97 Neur 1996;47:1148-1152 " Jun 97 Arch Neur 1997;54:625-630 Diagnosis, clinical Apr 97 Brain 1997;120:75-90 " , " Apr 97 J Neur N'Surg Psych 1997;62:245-252 DLBD Jun 96 J Neur N'surg Psych 1996;60:531-538 " ,FD-PET diagnosis Sep 96 Neur 1996;47:462-466 Dopamine, non-PD use Apr 97 BMJ 8 Mar 97:689-690 " receptors Nov 96 J Neurosci 1996;16:6579-6591 " " Feb 97 Movem't Dis 1997;12:33-38 " " Jul 97 Neur 1997;48:1589-1593 " storage sites Nov 96 J Neurosci 1996;16:4135-4145 " transporter Mar 96 Science 16 Feb 1996:909 " " Apr 97 J Neurosci 1997;17:960-974 " " Jul 97 Neur 1997;48:1578-1583 Down's syndrome Feb 95 Neur 1994;44:2419 Driving ability Feb 96 JAMA 17 Jan 1996:182 " Aug 96 J Neur N'surg Psych 1996;61:621-627 Drug Industry hype Nov 96 Time 21 Oct 1996:92 Dyskinesia Jul 96 Neur 1996;46:1548-1551 " Mar 97 Neur 1997;48:369-372 " , clozapine for Apr 97 Neur 1997;48:658-682 " , DA-induced May 97 Movem't Dis 1997;12:148-158 Eldepryl (selegiline) Dec 94 Ann Neur 1994;36;759-764 Electroconvulsive (PSP)Jun 96 Neur 1996;46:1284-1286 " (PD) Aug 96 J Neur N'surg Psych 1996;61:693-694 Encephalitis, childhoodJun 96 J Neur N'surg Psych 1996;60:589 Entacapone Feb 96 J Neur N'surg Psych 1996;60:36-40 Enteric nervous system Jun 96 NEJM 25 Apr 96:1106-15 Essential tremor, VIM Jun 96 Neur 1996;46:1150-1153 " , and PD Jun 96 Neur 1995;45:645-648 " , botulinum Jun 96 Neur 1995;45:822-824 " , migraine Jun 96 Neur 1996;46:458-460 " , etiology Jun 96 Neur 1996;46:1200-1205 " " Sep 96 Neur 1996;47:264-265 " " Mar 97 Ann Neur 1997;411:32-40 " , PET scan Jun 96 Ann Neur 1996;39:650-658 " Jan 97 Neur 1996;47:1331-1332 Ethanol and ET Jun 96 Ann Neur 1996;39:650-658 " Mar 97 Ann Neur 1996;40:950 Etiology of PD Jun 96 Neur 1996;46:1044-1050 " Jun 96 Neur 1996;46:1270-1274 " Jun 96 Neur 1996;46:1275-1284 " Aug 96 J Neur N'surg Psych 1996;61:4-16 " Sep 96 Arch Neur 1996;53;721 " Oct 96 Neur 1996;47:636-643 " Oct 96 Neur 1996;47:644-650 " Mar 97 Arch Neur 1997;54:145-150 " Apr 97 Neur 1997;48:650-658 Expression Jan 96 Neur 1995;45:1696-1702 Eye movement Jan 95 Neur 1994;44:2285 Fetal transplant Oct 95 Ann Neur 1995;38:379-388 " Apr 96 Brain 1996;119:41-50 " Dec 96 Lancet 26 Oct 1996;1159 " , fatal Jul 97 Neur 1997;48:1737-1738 " , FDA and Apr 97 Lancet 16 Mar 1997;784 " ,(pig) Nov 95 Science News 7 Oct 1995:230 " , " Mar 97 Science 24 Jan 1997:473 " , " Apr 97 BMJ 1 Mar 1997;625 " , " Jul 97 Nature Med 1997;3:474-475 " research Dec 96 J Neurosci 1996;16:6966-6974 " " Dec 96 J Neurosci 1996;16:7216-7227 " , effects Jul 97 J Neurosurg 1997;86:931-942 Fluctuations, nonmotor Jan 97 Neur 1996;47:1180-1183 Flunarizine Feb 97 Movem't Dis 1997;12:107-110 Food And Drug Adm. Jul 97 Nature Med 1997;3:477 Food habits and PD Oct 96 Neur 1996;47:636-643 Free radicals Jun 96 Science News 18 May 1996:311 Freezing, help for May 97 Movem't Dis 1997;12:206-215 Gabapentin for RLS May 97 Clin Neuropharm 1997;20:148-151 Gait, improvement Jul 96 Brain 1996;119:551-558 " impairment Jan 97 Brain 1996;119:1705-16 Gamma knife Jun 96 Ann Neur 1996;39:535-538 Ganglioside GM1 Sep 95 Neur 1995;45:1149-1154 GDNF Dec 96 J Neurosci 1996;16:7206-7215 " Jan 97 J Neurosci 1996;16:8132-8139 " Mar 97 Science 7 Feb 97:838-841 Gene CYP2D6, and risk Sep 96 Neur 1996;47:225-230 Gene, mutation Jun 95 Lancet 1995;345:958 " Jan 96 Neur 1995;45:1760-1763 " Dec 96 Science 15 Nov 96;1197-99 " Jan 97 BMJ 23 Nov 96;1278 " Jan 97 Ann Neur 1996;40:767-775 " Mar 97 Ann Neur 1997;41:277-281 " Jul 97 Ann Neur 1997;41:814 Gene transfer Aug 95 Science News 29 Jul 1995:73 " May 96 Science 12 Apr 1996;263 Glucose tolerance Jan 96 Int J Neur 1994;69:125-130 Glutamate antagonist Jun 96 Ann Neur 1996;39:574-578 " Jun 96 Ann Neur 1996;39:557-558 " Nov 96 J Neurosci 1996;16:4231-4239 " Nov 96 J Neurosci 1996;16:6394-6401 " , toxicity Jan 97 Science 6 Dec 1996:1612 Glutamic acid RNA Sep 96 Neur 1996;47:219-224 Guillain-Barre Sep 95 Ann Neur 1995;38:218-224 Hallucinations Jun 96 Neur 1995;45:659-671 " Jan 97 Arch Neur 1996;53:1265-1268 Heredity Apr 95 Neur 1995;45:502-506 " Oct 95 Ann Neur 1995;38:373-378 " Feb 96 Science News 6 Jan 96:4 " Jun 96 Neur 1996;46:1275-1284 " Sep 96 Neur 1996;47:155-160 " Sep 96 Neur 1996;47:160-166 " Mar 97 Ann Neur 1997;41:265-268 " Mar 97 Ann Neur 1997;41:222-229 Histaminergic neurons Jul 96 Neur 1996;46:1693-1696 Hitler's PD observed May 97 Movem't Dis 1997;12:239-240 Hydrocarbon, caused by Mar 97 Ann Neur 1996;40:922-925 Incidence (survey) Jun 97 Neur 1997;48:1277-1281 " , Argentina May 97 Movem't Dis 1998;12:197-205 Inderal, for dyskinesiaJul 96 Neur 1996;46:1548-1551 Iron, possible cause Jul 96 Lancet 8 Jun 1996;1614 Iron, elevated Jan 95 Ann Neur 1994;36;876-881 " Oct 95 Neur 1995;45:1138-1143 Juvenile PD Sep 96 Neur 1996;47:160-166 Kava Jun 95 J Neur N'surg Psych 1995;58:639-640 Keats, John Jan 95 Arch Neur 1994;51:1182-1183 Lamotrigine Jun 97 Neur 1997;48:1282-1286 Lazabemide Aug 96 Ann Neur 1996;40:99-107 Leukemia drugs Jul 95 Ann Neur 1995;37:810-814 Levodopa strategy Oct 95 Ann Neur 1995;38:389-395 " Dec 95 J Neur N'surg Psych 1995;59:555 " Feb 97 Neur 1996;47:Supp 3 Levodopa effects Jan 96 Neur 1995;45:1757-1760 " Jun 96 Neur 1996;46:1430-1436 " Aug 96 J Neur N'surg Psych 1996;61:634-637 " Feb 97 Movem't Dis 1997;12:103-106 Levodopa ethylester Apr 96 Ann Neur 1996;39:400-404 Levodopa dual-release May 97 Clin Neuropharm 1997;20:130-139 Lewy body disease Jun 96 J Neur N'surg Psych 1996;60:531-538 " Sep 96 Neur 1996;47:462-466 " Mar 97 Neur 1997;48:376-380 Liquid Sinemet Feb 97 Neur 1996;47:1493-1495 Locus coeruleus Jun 95 Brain 1995;118:131-143 Machado-Joseph Nov 95 Ann Neur 1995;38:684-687 Macrophage Oct 96 Science News 21 Sep 96:180 Magnetic stimulation May 96 Brain 1996;119:71-77 " Sep 96 Brain 1996;119:815-822 " Oct 96 Ann Neur 1996;40:344-355 MAO inhibition, effect May 97 J Neurosci 1997;17:2267-2272 MAO-B Jun 96 Neur 1996;46:1262-1269 " Aug 96 Ann Neur 1996;40:99-107 Markers, neurochemical Oct 96 Neur 1996;47:718-726 " " May 97 Movem't Dis 1997;12:167-174 " " May 97 Ann Neur 1997;41;530-539 Melatonin Jun 96 BMJ 18 May 96:1242-43 " , antioxidant Apr 97 J Neurosci 1997;17:1683-1690 Memory, Hippocampus Oct 96 Science News 7 Sep 1996:150 Memory and PD Oct 96 Science 6 Sep 96:1263-64 " Oct 96 Science 6 Sep 96:1399-02 " Jun 97 J Neur N'surg Psych 1997;62:410-413 Menstrual effects Jul 95 Neur 1995;45:1028 " Nov 95 Movem't Dis 1993;8:240-241 Metaclopramide (Reglan)Jan 96 JAMA 1995;274:1780-82 Metals, exposure to Apr 97 Neur 1997;48:650-658 Methylsalsolinol Aug 96 Ann Neur 1996;40:119-122 Metronome Jun 96 Lancet 11 May 1996:1337 Migraine, DA and May 97 Clin Neuropharm 1997;20:36-41 Mimics of PD Oct 95 Arch Neur 1995;58:294-298 " Oct 95 Brain 1995;118:951-958 " Apr 96 BMJ 16 Mar 1996:724 Mitochondria Sep 95 Science News 5 Aug 1995;84 " Feb 96 Neur 1995;45:2097-2099 " Feb 97 Movem't Dis 1997;12:3-16 Mortality Apr 95 J Neur N'surg Psych 1995;58:293-299 " Apr 97 Arch Neur 1997;54:260-264 Motor Fluctuations Aug 96 J Neur N'surg Psych 1996;61:634-637 Movement, head and eye Jul 96 Ann Neur 1996;39:749-760 " , coordinated Apr 97 Brain 1997;120:91-102 " , " Jun 97 Brain 1997;120:593-604 " , diagnostic May 97 Arch Neur 1997;54:450-454 MPTP Dec 94 Ann Neur 1994;36:765-770 " Jan 97 J Neurosci 1996;16:7776-7782 " Feb 97 Neur 1996;47:Supp 3 Multiple System AtrophyMar 95 Ann Neur 1995;37:204-210 " Sep 95 J Neur N'surg Psych 1995;59:144-151 Muscle, sound from Apr 97 Lancet 22 Feb 97;533-535 Nerve Growth Factor Apr 96 J Neurosurg 1996;84:685-689 " Nov 96 J Neurosci 1996;16:5437-5442 " Nov 96 J Neurosci 1996;16:6433-6442 " Jul 97 J Neurosurg 1997;86:511-518 " and diabetes Nov 96 Lancet 19 Oct 96:1044-45 Neuroleptics (risk) Mar 96 J Neur N'surg Psych 1996;60:213-216 Neuropeptides Sep 96 Brain 1996;119:823-830 Neurosciences Inst. Dec 95 Science 27 Oct 1995:572 Neurotrophic factors Oct 96 Ann Neur 1996;40:346 " problems Jul 97 Nature Med 1997;3:497 " (BDNF) May 97 J Neurosci 1997;17:2295=2313 Neurotrophic (GDNF) Apr 96 WSJ 21 Mar 1996: " Jan 97 N Neurosci 16:8132-8139 NMDA antagonist Nov 96 J Neurosci 1996;16:4231-39 " May 97 J Neurosci 1997;17:2921-2927 Nurr-1 May 97 Science 11 Apr 97:248-50 " , editorial May 97 Science 11 Apr 97:202 Nutrients and PD Oct 96 Neur 1996;47:644-650 Olfaction and PD Jul 97 J Neur N'surg Psych 1997;62:436-446 Ondansetron (Zofran) Oct 95 Neur 1995;45:1305-1308 " Feb 97 Neur 1996;47:1608-1609 " , for tremor Apr 97 J Neur N'Surg Psych 1997;62:282-284 On-off effect Dec 95 J Neur N'surg Psych 1995;59:555 " Aug 96 J Neur N'surg Psych 1996;61:634-637 Oxidative stress May 95 Neur 1995;45S3:55 " Aug 95 J Neur N'surg Psych 1995;59:90-91 " Apr 96 Ann Neur 1996;39:378-381 Pallidopyramidal Feb 96 Ann Neur 1995;38:954-956 Pallidotomy, boom in Mar 95 WSJ 22 Feb 95:1 " , PET scan Jul 95 Ann Neur 1995;37:776-783 " , benefits Jun 96 Neur 1995;45:753-761 " , " Jul 96 Lancet 25 May 96;1490 " , " Jul 96 Ann Neur 1996;39:826 " , " Apr 97 J Neur N'Surg Psych 1997;62:125-132 " , " Apr 97 Lancet 15 Mar 1997:777 " , " Jun 97 Neur 1997;48:1273-1277 " , " Jul 97 Ann Neur 1997;41:834 " , gamma knife Jun 96 Ann Neur 1996;39:535-538 " , PET scan Jun 96 Ann Neur 1996;39:450-459 " , technique Jul 96 J Neurosurg 1996;84:194-202 " , " Jan 97 J Neurosurg 1996;85:1005-1012 " , history Oct 96 Ann Neur 1996;40:341-343 " , success Oct 96 Ann Neur 1996;40:355-366 " and DBS Jul 97 Nature Med 1997;3:671-674 " " " Jul 97 Nature Med 1997;3:602-603 " , low-cost Jul 97 Brain 1997;120:729-737 Paroxetine (Paxil) Jan 95 Neur 1994;44:2406 Pathways, neural May 95 Neur 1995;45S3:S28-S34 " Nov 96 Neur 1996;1032-1036 Perception, visual May 96 Brain 1996;119:79-87 Pergolide (Permax) May 95 Neur 1995;45S3:S5 " May 95 Neur 1995;45S3:S13-S21 " May 95 Neur 1995;45S3:S22-S27 Personality and PD Mar 97 Lancet 15 Feb 97:478 PET diagnosis Dec 94 Ann Neur 1994;36:759-764 " Dec 94 Ann Neur 1994;2:176-182 " Jan 96 J Neur N'surg Psych 1995;59:597-600 " Feb 96 Neur 1995;45:1995-2004 " Jun 96 Ann Neur 1996;39:450-459 " Jun 96 Neur 1996;46:1430-1436 " Jun 96 Neur 1996;46:1200-1205 " Jun 96 Ann Neur 1996;39:650-658 " Jul 96 Brain 1996;119:585-591 " Sep 96 Neur 1996;47:462-466 " Mar 97 Ann Neur 1996;40:873-884 " Mar 97 Ann Neur 1997;41:58-64 " scans, questioned May 97 Science 11 Apr 97:196-198 Porphyria and PD drugs Jul 97 J Neur N'surg Psych 1997;62:562 Pramipexole Apr 96 PDF Newsletter Spr 1996:1 Prevalence Mar 97 J Neur N'surg Psych 1997;62:10-15 Prions May 96 Science News 13 Apr 1996;228 Progenitor cells Nov 95 Eng. & Sci Sept 95:26 Progression (case hist)Feb 96 NEJM 1996;334:116-118 " Apr 96 JAMA 6 Mar 1996:716 " Nov 96 JAMA 9 Oct 1196;1171 " , in putamen Mar 97 Brain 1996;119:2097-103 Progressive Supranuc. Jun 96 J Neur N'surg Psych 1996;60:589 " Aug 96 J Neur N'surg Psych 1996;61:615-620 " Sep 96 Neur 1996;47:1-9 " Sep 96 Neur 1996;47:148-154 " Apr 97 Brain 1997;120:65-74 Propranolol Jul 96 Neur 1996;46:1548-1551 Propath program Oct 96 Arch Neur 1996;53:881-884 Proton Magnetic Res. Apr 97 J Neur N'Surg Psych 1997;62:239-242 Prozac (fluoxetine) Nov 95 Neur 1995;45:1855-1858 Psychogenic PD Sep 95 Arch Neur 1995;52:802-810 Quality of life Aug 96 J Neur N'surg Psych 1996;61:71-74 Raclopride, in PET Feb 97 Movem't Dis 1997;12:33-38 Rapid-onset May 97 Neur 1997;49:1066-1069 Reaction time Dec 95 J Neur N'surg Psych 1995;59:499-506 " Jan 97 Brain 1996;119:1689-1704 Reflex blink, and PD Dec 96 J Neurosci 1996;16:7308-7330 Regeneration, brain Apr 96 Lancet 16 Mar 1996:751 " Oct 96 Science News 21 Sep 1996:180 " Apr 97 Science 28 Feb 97;1318-19 " , spinal cord Oct 96 Lancet 21 Sep 1996:814 Registry (surveys) Feb 96 Neur 1995;45:1991-1995 " Feb 96 NEJM 1996;334:71-76 " Feb 96 Neur 1995;45:2143-2146 " Feb 96 Arch Neur 1996;53:66-71 Research priorities Nov 95 JAMA 25 Oct 95:1257-8 Response time, levodopaJun 96 Neur 1996;46:1055-1058 " Jun 96 Neur 1996;46:1059-1062 Restless leg syndrome Feb 96 JAMA 17 Jan 1996: " Feb 97 Neur 1996;47:1435-1441 " May 97 Clin Neuropharm 1997;20:148-151 Rigidity Feb 97 Movem't Dis 1997;12:24-32 Risperidone Feb 97 Movem't Dis 1997;12:119-121 Salsolinol Aug 96 Ann Neur 1996;40:119-122 Selegiline , PET scan Dec 94 Ann Neur 1994;36:759-764 " , and AD May 97 NEJM 14 Apr 97:1216-22 " , benefits Feb 95 Ann Neur 1995;37:95-98 " , " May 97 Movem't Dis 1997;12:175-182 " ' " Jul 97 Ann Neur 1997;41:833-834 " , DATATOP Apr 95 Arch Neur 1995;52:237-245 " , " Nov 95 Arch Neur 1995;52:564-570 " , " Mar 96 Ann Neur 1996;39:37-45 " , " Mar 96 Ann Neur 1996;39:29-36 " , amphetamine Oct 95 Lancet 1995;346:64 " , protection by Jan 96 Ann Neur 1995;38:771-777 " , risks of Jan 96 BMJ 16 Dec 95:1602-7 " , " Mar 97 Ann Neur 1996;40:841-845 " , " Apr 97 Neur 1997;48:662-667 " , in favor of Apr 96 PDF Newsletter Spr 1996:2 " , pro and con Apr 96 BMJ 16 Mar 96:702-705 " , " " " Sep 96 Ann Neur 1996;40:266-269 " , " " " Mar 97 Ann Neur 1997;41:282-283 ", special review Feb 97 Neur 1996;47:Supp 3 Serotonin syndrome Maw 97 Neur 1997;48:1070-1077 Shy-Drager Mar 95 Ann Neur 1995;37:204-210 Sinemet CR Jul 95 J Neur N'surg Psych 1995;58:ad " Dec 95 Lancet 11 Nov 1995;1290 Sjogren's syndrome Feb 97 Movem't Dis 1997;12:121-123 Sleep, violence in Jun 97 Lancet 19 Apr 97;1150 Smell, loss of Jul 97 J Neur N'surg Psych 1997;62:436-446 Smoking and PD Sep 95 Neur 1995;45:1041 " Oct 95 Neur 1995;58:294-298 " Apr 96 Time 11 Mar 1996:60 " Apr 96 Lancet 24 Feb 1996:527 " Apr 96 Ann Neur 1996;39:378-381 " Jun 96 Neur 1996;46:1275-1284 SPECT, diagnosis by Apr 96 Neur 1996;46:278-285 " Apr 96 Neur 1996;46:231-237 " Apr 97 Brain 1997;120:103-110 " Apr 97 J Neur N'Surg Psych 1997;62:133-140 Speech therapy Feb 97 Neur 1996;47:1496-1504 Stem cells, review of May 97 Science 4 Apr 1997:66-71 Stereotactic Aug 95 J Neurosurg 1995;83:197-205 " Apr 96 Science News 30 Mar 1996:204 Stimulation, chronic Jun 96 Neur 1996;46:1150-1153 " Oct 96 Arch Neur 1996;53:898-903 Strategy, summary May 97 Clin Neuropharm 1997;20:95-115 Strength, arm Mar 96 Ann Neur 1996;39:79-88 " Jun 97 Brain 1997;120:401-408 Striatonigral degener- Nov 96 Neur 1996;47:1032-1036 Stroke, help from Feb 97 Movem't Dis 1997;12:124-126 " , adverse effect Apr 97 J Neur N'Surg Psych 1997;62:288-289 Surgery, summary Mar 97 J Neur N'surg Psych 1997;62:2-8 Swallowing Mar 97 Neur 19977;48:373-375 Sweats, control of Mar 95 Ann Neur 1995;37:120-122 Symmetrel (Amantadine) Jul 96 Neur 1996;46:1551-1556 Tardive dyskinesia Feb 97 Movem't Dis 1997;12:119-121 " " , and PVP Apr 97 Lancet 15 Mar 1997:777 Tacrine, PD symptoms Oct 96 J Neur N'surg Psych 1996;61:324-325 Thalamotomy Jun 96 J Neur N'surg Psych 1996;60:564-571 " Jan 97 Brain 1996;1717-1727 " Mar 97 Ann Neur 1997;41:108-111 Thalamus, and tremor Mar 96 Neur 1996;46:75-79 " Jun 96 Neur 1996;46:1150-1153 Therapy, tutorial Jul 96 Western J Med 1994;161:303-308 " Jul 96 Postgrad Med 1996;99:52-68 Time, judgement of Mar 96 Science News 17 Feb 1996:101 " May 96 Brain 1996;119:51-70 Tolcapone Feb 97 Neur 1997;48:81-87 Toxins, Environmental Dec 94 Ann Neur 1994;36:765-770 " Apr 95 Neur 1995;45:435-439 " Feb 96 Neur 1995'45:2112 " Jul 97 Neur 1997;48:1583-1588 Tracking, visual Jun 95 Brain 1995;118:485-493 Transcranial mag. stim May 97 J Neurosci 1997;17:3178-3184 Tremor, resting PD Jun 96 Neur 1996;46:1359-1370 ", cerebellar Apr 97 J Neur N'Surg Psych 1997;62:282-284 ", surgery for may 97 J Neurosurg 1997;86:642-647 Ubiquitin Feb 96 Brain 1995;118:1447-49 Urinary dysfunction Jul 97 J Neur N'surg Psych 1997;62:507-511 Valproate Oct 96 Neur 1996;47:626-635 Visual perception May 96 Brain 1996;119:79-87 Vision abnormality Oct 95 Neur 1995;45:1144-1148 Visuospatial attention Jun 95 Brain 1995;118:153-166 Weight loss Feb 97 Neur 1997;48:88-91 Wine and dementia May 97 BMJ 5 Apr 97:997 Young Onset Sep 96 Neur 1996;47:225-230 Zolpidem Jun 97 Lancet 26 Apr 97;1222-23 J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013